Erythropoietin for Infants With Brain Injuries Due to Oxygen Deprivation at Birth
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Erythropoietin (Epo) is a hormone normally found in the body that may protect brain cells
from damage due to lack of oxygen. This study will evaluate the safety of high-dose Epo in
infants who did not get enough oxygen during birth.
Phase:
Phase 1
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)